Adage Capital Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $46.5M | Buy |
|
|||||
|
2025
Q2 | $31.1M | Buy |
|
|||||
|
2025
Q1 | $9.68M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $8.88M | Sell |
|
|||||
|
2024
Q2 | $31.9M | Sell |
|
|||||
|
2024
Q1 | $54.2M | Sell |
|
|||||
|
2023
Q4 | $92.1M | Buy |
|
|||||
|
2023
Q3 | $15.7M | Sell |
|
|||||
|
2023
Q2 | $115M | Buy |
|
|||||
|
2023
Q1 | $92.3M | Buy |
|
|||||
|
2022
Q4 | $61.6M | Sell |
|
|||||
|
2022
Q3 | $66.2M | Buy |
|
|||||
|
2022
Q2 | $31.1M | Buy |
|
|||||
|
2022
Q1 | $3.88M | Sell |
|
|||||
|
2021
Q4 | $43.5M | Buy |
|
|||||
|
2021
Q3 | $32M | Sell |
|
|||||
|
2021
Q2 | $46.9M | Sell |
|
|||||
|
2021
Q1 | $48.1M | Buy |
|
|||||
|
2020
Q4 | $41.5M | Sell |
|
|||||
|
2020
Q3 | $50.2M | Buy |
|
|||||
|
2020
Q2 | $14.9M | Sell |
|
|||||
|
2020
Q1 | $65.1M | Sell |
|
|||||
|
2019
Q4 | $61.9M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $26.9M | Sell |
|
|||||
|
2018
Q4 | $74.4M | Sell |
|
|||||
|
2018
Q3 | $91.4M | Sell |
|
|||||
|
2018
Q2 | $81.3M | Sell |
|
|||||
|
2018
Q1 | $77.9M | Sell |
|
|||||
|
2017
Q4 | $95.5M | Buy |
|
|||||
|
2017
Q3 | $76.8M | Sell |
|
|||||
|
2017
Q2 | $72.9M | Sell |
|
|||||
|
2017
Q1 | $76.1M | Sell |
|
|||||
|
2016
Q4 | $86.5M | Sell |
|
|||||
|
2016
Q3 | $95.5M | Sell |
|
|||||
|
2016
Q2 | $76.8M | Sell |
|
|||||
|
2016
Q1 | $97.4M | Buy |
|
|||||
|
2015
Q4 | $69M | Sell |
|
|||||
|
2015
Q3 | $112M | Sell |
|
|||||
|
2015
Q2 | $232M | Buy |
|
|||||
|
2015
Q1 | $188M | Buy |
|
|||||
|
2014
Q4 | $144M | Sell |
|
|||||
|
2014
Q3 | $182M | Buy |
|
|||||
|
2014
Q2 | $102M | Sell |
|
|||||
|
2014
Q1 | $139M | Sell |
|
|||||
|
2013
Q4 | $193M | Sell |
|
|||||
|
2013
Q3 | $216M | Buy |
|
|||||
|
2013
Q2 | $187M | Buy |
|